Still, the TCGA-obtained data suggest a potential negative correlation between transcript levels of EGLN2 and EGLN3 and DNA methylation of their promoter region, as well the impact of this DNA methylation on HNSCC patients’ overall survival. This evidence concerns the gene EGLN3 and head and neck squamous cell carcinoma.